Ad Scientiam Launches International Study to Assess Disabili

Ad Scientiam Launches International Study to Assess Disability Progression in multiple sclerosis with MSCopilot®Paris, 12 September, 2023 – Ad Scientiam, a global leader in digital biomarkers has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-...

Related Keywords

France , Italy , Spain , Denmark , Germany , Canada , Paris , France General , United States , America , Saad Zina , Novartis , Study Steering Committee , Instagram , Facebook , Paris Brain Institute , Pfizer , Linkedin , Global Head Of Medical Affairs , Assess Disability Progression , Expanded Disability Status Scale , Multiple Sclerosis Functional Composite , Chief Medical Officer , Global Head , Medical Affairs , Patrick Vermersch , Coordinating Investigator , Study Steering , North America , Quality Management System ,